SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

   Biotech / MedicalNNVC - NanoViricides, Inc.


Previous 10 Next 10 
To: drkaz who wrote (12850)10/14/2022 10:39:07 AM
From: old 'n cranky
   of 12868
 
The press release that you provided to this board 5 years ago and that to this day remains as an introduction was promising too, wasn't it?

Using the word "promising" in a post about NNVC is shameful. Tell us why you continue to do so after having been shown to be wrong for so long.

Share RecommendKeepReplyMark as Last Read


To: drkaz who wrote (12850)10/14/2022 10:43:35 AM
From: Savant
   of 12868
 
"sounds promising".....It always does...

Share RecommendKeepReplyMark as Last Read


To: Savant who wrote (12844)11/3/2022 3:17:05 PM
From: HardToFind
   of 12868
 
If history is any guide, any such bounce could be sold short as soon as it crests...
Management's history is to over-promise and under-deliver. Given their history, unless there is a substantial change in management & governance, you can count on a drop following every pop in the stock price.

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: HardToFind who wrote (12853)11/3/2022 3:29:06 PM
From: Savant
   of 12868
 
HTF...unless, wonder of all wonders...they actually produce something, or mebbe even if they enter clinical trials..

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: Savant who wrote (12854)11/29/2022 4:35:22 PM
From: HardToFind
   of 12868
 
If history is any guide, any such bounce could be sold short as soon as it crests...
Management's history is to over-promise and under-deliver. Given their history, unless there is a substantial change in management & governance, you can count on a drop following every pop in the stock price.
HTF...unless, wonder of all wonders...they actually produce something, or maybe even if they enter clinical trials.
Unless there's a change in management, I think we'd all be safe in shorting...

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: HardToFind who wrote (12855)11/29/2022 4:41:22 PM
From: Savant
1 Recommendation   of 12868
 
HTF...well...over promise, yes...under deliver..no....They've never delivered anything...other than PRs

Share RecommendKeepReplyMark as Last Read


From: old 'n cranky1/5/2023 9:49:04 AM
   of 12868
 
Did Diwan vote against the proposal to move the organization's domicile to Delaware? Wouldn't it have passed if he (and his controlled TheraCour property) voted for it?

Share RecommendKeepReplyMark as Last Read


From: old 'n cranky4/3/2023 4:20:34 PM
   of 12868
 
I guess the news isn't blockbuster quality after all. Nobody seems to have noticed.

Share RecommendKeepReplyMark as Last Read


From: mattstat4/10/2023 5:01:49 PM
   of 12868
 
The sham continues...

Share RecommendKeepReplyMark as Last Read


From: Savant4/10/2023 7:25:13 PM
   of 12868
 
What caused the pump....deal w/co in India to evaluate & license...
However, Diwan has his fingers in and gets a big cut, in that co. and all the others....arrgh

NanoViricides Signs a License Agreement That Includes Clinical Evaluation of Its COVID-19 Drug Candidates | BioSpace

About Karveer Meditech Private Limited

Karveer Meditech Private Limited is a small and aspiring dynamic pharmaceutical company in India. It has developed and commercialized in local markets more than a dozen different generic and semi-branded pharmaceutical drugs as well as Ayurvedic medicines and vitaminized nutritional supplement protein powder products. It was co-founded by Dr. Anil Diwan, who serves as a Director and is a passive investor. Dr. Diwan is also co-founder of and President and Chairman of the Board of NanoViricides. Karveer Meditech is independently managed by its Managing Director in India.

Share RecommendKeepReplyMark as Last Read
Previous 10 Next 10